Evidence map›Paper›PMID 29538545›Full record

ReviewJornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia

Lung cancer in Brazil.

Luiz Henrique Araujo, Clarissa Baldotto, Gilberto de Castro, Artur Katz, Carlos Gil Ferreira, Clarissa Mathias, Eldsamira Mascarenhas, Gilberto de Lima Lopes, Heloisa Carvalho, Jaques Tabacof and 11 more

Registry-linked trialAbstract readReview
In one paragraph

Review in Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05863013 (Longitudinal Changes in the ADL-Glittre Test in Patients With Lung Cancer), which is not on this map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05863013 naunknown statusnot on this map

Longitudinal Changes in the ADL-Glittre Test in Patients With Lung Cancer: Pre- and Postoperative Analysis Using Rehabilitation in a Randomized Controlled Trial

TypeinterventionalSponsorCentro Universitário Augusto MottaRan2023 to 2024Enrolled80ConditionsLung Cancer, Nonsmall Cell, Quality of Life, Physical Disability, SurgeryArmsADL-Glittre Test
3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer.Journal of cancer research and clinical oncology · 2023
    Review
  10. Observational
  11. Article
  12. Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Genes · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Luiz Henrique Araujo. Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA - Rio de Janeiro (RJ) Brasil.ORCID http://orcid.org/0000-0001-9486-7139
Clarissa Baldotto. Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA - Rio de Janeiro (RJ) Brasil.ORCID http://orcid.org/0000-0001-9539-3094
Gilberto de Castro. Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira - Icesp - São Paulo (SP) Brasil.ORCID http://orcid.org/0000-0001-8765-3044
Artur Katz. Centro de Oncologia, Hospital Sírio-Libanês, São Paulo (SP) Brasil.ORCID http://orcid.org/0000-0002-1811-1169
Carlos Gil Ferreira. Instituto D'Or de Pesquisa e Ensino, Rio de Janeiro (RJ) Brasil.ORCID http://orcid.org/0000-0002-7228-7018
Clarissa Mathias. Núcleo de Oncologia da Bahia, Salvador (BA) Brasil.ORCID http://orcid.org/0000-0002-6219-9858
Eldsamira Mascarenhas. Núcleo de Oncologia da Bahia, Salvador (BA) Brasil.ORCID http://orcid.org/0000-0001-6107-5098
Gilberto de Lima Lopes. Centro Paulista de Oncologia, São Paulo (SP) Brasil.ORCID http://orcid.org/0000-0002-1151-9903
Heloisa Carvalho. Centro de Oncologia, Hospital Sírio-Libanês, São Paulo (SP) Brasil.ORCID http://orcid.org/0000-0003-0979-7768
Jaques Tabacof. Centro Paulista de Oncologia, São Paulo (SP) Brasil.
Jeovany Martínez-Mesa. Faculdade Meridional IMED, Passo Fundo (RS) Brasil.ORCID http://orcid.org/0000-0003-2540-4506
Luciano de Souza Viana. Hospital de Câncer de Barretos, Barretos (SP) Brasil.ORCID http://orcid.org/0000-0001-8506-4414
Marcelo de Souza Cruz. Centro Oncológico Antônio Ermírio de Moraes, São Paulo (SP) Brasil.ORCID http://orcid.org/0000-0001-9496-4596
Mauro Zukin. Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA - Rio de Janeiro (RJ) Brasil.ORCID http://orcid.org/0000-0002-6439-3136
Pedro De Marchi. Hospital de Câncer de Barretos, Barretos (SP) Brasil.ORCID http://orcid.org/0000-0001-5259-0215
Ricardo Mingarini Terra. Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira - Icesp - São Paulo (SP) Brasil.ORCID http://orcid.org/0000-0001-8577-8708
Ronaldo Albuquerque Ribeiro. Instituto do Câncer do Ceará, Fortaleza (CE) Brasil.
Vladmir Cláudio Cordeiro de Lima. A.C. Camargo Cancer Center,São Paulo (SP) Brasil.ORCID http://orcid.org/0000-0003-3955-1101
Gustavo Werutsky. Latin American Cooperative Oncology Group - LACOG - Porto Alegre (RS) Brasil.ORCID http://orcid.org/0000-0001-6271-105X
Carlos Henrique Barrios. Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre (RS) Brasil.ORCID http://orcid.org/0000-0001-6021-667X
Grupo Brasileiro de Oncologia Torácica

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is one of the most incident types of cancer and a leading cause of cancer mortality in Brazil. We reviewed the current status of lung cancer by searching relevant data on prevention, diagnosis, and treatment in the country. This review highlights several issues that need to be addressed, including smoking control, patient lack of awareness, late diagnosis, and disparities in the access to cancer health care facilities in Brazil. We propose strategies to help overcome these limitations and challenge health care providers, as well as the society and governmental representatives, to work together and to take a step forward in fighting lung cancer.

Indexed as

BrazilFemaleHealth Services AccessibilityHumansLung NeoplasmsMaleRisk FactorsSex DistributionTime Factors

Identifiers

PMID29538545
PMCPMC6104542

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.